Eli Lilly And Company Earnings logo

LLY

Eli Lilly And Company Earnings

$763.02

Earnings Summary

Revenue
$12728.5Mn
Net Profits
$2759.3Mn
Net Profit Margins
21.68%
PE Ratio
62.11
Highlights
Revenue:

Eli Lilly And Company’s revenue jumped 45.17% since last year same period to $12728.5Mn in the Q1 2025. On a quarterly growth basis, Eli Lilly And Company has generated -5.94% fall in its revenue since last 3-months.

Net Profits:

Eli Lilly And Company’s net profit jumped 23.02% since last year same period to $2759.3Mn in the Q1 2025. On a quarterly growth basis, Eli Lilly And Company has generated -37.43% fall in its net profits since last 3-months.

Net Profit Margins:

Eli Lilly And Company’s net profit margin fell -15.26% since last year same period to 21.68% in the Q1 2025. On a quarterly growth basis, Eli Lilly And Company has generated -33.47% fall in its net profit margins since last 3-months.

PE Ratio:

Eli Lilly And Company’s price-to-earnings ratio after this Q1 2025 earnings stands at 62.11.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Eli Lilly And Company post its latest quarter earnings
EPS Estimate Current Quarter
3.46
EPS Estimate Current Year
3.46
Highlights
EPS Estimate Current Quarter:

Eli Lilly And Company’s earning per share (EPS) estimates for the current quarter stand at 3.46 - a -31.77% fall from last quarter’s estimates.

EPS Estimate Current Year:

Eli Lilly And Company’s earning per share (EPS) estimates for the current year stand at 3.46.

Key Ratios

Key ratios of the Eli Lilly And Company post its Q1 2025 earnings
Earning Per Share (EPS)
3.34
Return on Assets (ROA)
0.16
Return on Equity (ROE)
0.77
Dividend Per Share (DPS)
1.5
Highlights
Earning Per Share (EPS):

Eli Lilly And Company’s earning per share (EPS) jumped 29.46% since last year same period to 3.34 in the Q1 2025. This indicates that the Eli Lilly And Company has generated 29.46% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Eli Lilly And Company’s return on assets (ROA) stands at 0.16.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Eli Lilly And Company’s return on equity (ROE) stands at 0.77.

Dividend Per Share (DPS):

Eli Lilly And Company declared 1.5 dividend per share during the earnings announcement for Q1 2025.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2025-05-01
3.46
3.34
-3.39%

Discover More Earning Stocks in Health Technology Sector